Generic Name: Infliximab
Brand Name: Remsima
Manufacturer: Fresenius Kabi Canada
Indications: Ankylosing spondylitis, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis
Submission Type: New
Project Status: Withdrawn
Biosimilar: Yes
Infliximab
Last Updated: May 30, 2014
Result type: Reports
Project Number: SE0383-000
Product Line: Common Drug Review